Qstent Coronary Stent System
Qvanteq has developed the Qstent Coronary Stent System in a comprehensive range of length/diameter combinations. Animal studies conducted by CBSET (www.cbset.org) showed reduced neointimal hyperplasia and improved endothelialization compared to commercially available and untreated stents.
The surface technology has shown to be safe in a first in man clinical study (QUEST I on clinicaltrials.gov, status: completed).
For further information, please contact the company.